Abstract:Objective The association of high-sensivity C-reactive protein (hs-CRP) on patients undergoing percutaneous coronary intervention (PCI) and the long-term prognostic value were evaluated.Methods A prospective cohort study was prospectively conducted in 287 consecutive patients who were hospitalized in the Department of Cardiology of Shanghai Zhongshan Hospital undergoing primary PCI between Dec.2007 and Dec.2008.Levels of hs-CRP and other cardiovascular risk factors were determined before PCI.The patients were followed up for a mean of 54 months.Their cardiovascular end points were recorded.Results The mean value of serum hs-CRP in patients with cardiovascular disease (CVD) readmission and death was significantly higher than those without CVD readmission and death (2.21 mg/L versus 1.10 mg/L,Z=-3.152;6.60 mg/L versus 1.22 mg/L,Z=-3.192;P both ＜0.05).The cardiac troponin T,WBC,multivessel disease,stent placement and the low HDL-C are the factors relating to serum hs-CRP levels.The coefficients of correlation have statistical significance (t =8.575,4.763 and -2.770;P ＜0.05).The odd ratios for CVD readmissiom and CVD death were 1.714(95％ CI,1.164-2.523)and 5.023 (95 ％ CI,2.003-12.600).Kaplan-Meier survival analysis demonstrated a significantly reduced 5-year readmission rate in patients with 3.65 ＜ hs-CRP ≤ 82.51 mg/L [43.75％ (30/71) groups versus the lower hs-CRP level groups(20.83％,15/72) ; x2 =10.375,P ＜ 0.001by Log-rank].The same as the death rate [9.86％ (7/71) were evaluated in the lower hs-CRP level groups (1.38％,1/72) ;x2 =11.362,P ＜0.05 by Log-rank].The readmission rate and mortality in the patients with hs-CRP ＞3.0 mg/ L are 43.75％ (35/80)and 8.75％ (7/80),respectively.The survival time was all less than 20 months.Conclusions The results demonstrated that hs-CRP is an independent risk factor in cardiovascular disease.High hs-CRP is strongly associated with 5-year occurance of readmission and death for cardiovascular events.Hs-CRP can be a strong indicator of risk stratification and prognostic evaluation on cardiovascular high-risk populations.

Changes of C Reactive Protein Level in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention

The Serum Levels of High Sensitivity C-reactive Protein and Cardiac Events after Percutaneous Coronary Intervention

[Changes of Plasma High-Sensitive C-reactive Protein and Monocyte Chemotactic Factor-1 Following Percutaneous Coronary Interventional Procedures in Patients with Coronary Artery Disease].

Changes of the Serum Level of C-reactive Protein after Coronary Angioplasty

Predictive Value of Baseline C-reactive Protein for Periprocedural Myocardial Infraction of Higher Risk Stratifications: A Retrospective Cohort Clinical Study

C-Reactive Protein and Inflammatory Cytokines During Percutaneous Coronary Intervention

Change of Serum Level of Platelet Activity and Inflammation Factors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention and Their Clinical Significance

Temporal Changes in Circulating P-selectin, Plasminogen Activator Inhibitor-1, Magnesium, and Creatine Kinase after Percutaneous Coronary Intervention

Effect of percutaneous coronary intervention on inflammatory reactions and platelet activation in patients with acute coronary syndrome

C-reactive Protein and Other Cardiovascular Biomarkers Are Prediction of Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention

Significance of plasma PAPP-A and CRP change after percutaneous coronary intervention

The effect on vascular endothelial growth factor and C-reactive protein levels before and after coronary intervention treatment of coronary heart disease

The Changes of Serum C-reactive Protein Level in Patients with Coronary Artery Disease and Its Clinical Significance

The Change and Signficance of High-Sensitivity C-reactive Protein Level in Different Therapies for Patients with Acute Myocardial Infarction

Changes of Serum Interleukin- 10 and Interleukin- 18 Before and After Coronary Intervention Therapy and Its Correlation with Cardiovascular Events

Relationship Between High Sensitivity C-Reactive Protein and Contrast Induced Nephropathy

Elevated High Sensitive C-reactive Protein and Apelin Levels after Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation

Value of hypersensitive C-reactive protein for predicting the prognosis of patients after emergent percutaneous coronary intervention

Change of Platelet Activity and Vascular Endothelium Function in Patients with Acute Coronary Syndrome After Treatment by Percutaneous Coronary Intervention

The Value of Preprocedural Serum Levels of C-reactive Protein in Predicting Cardiovascular Events and Restenosis after Coronary Stent Implantation

Changes of the serum high-sensitivity C-reactive protein and uric acid level in male patients with coronary heart disease and its clinical significance